Meyonex pharmaceutical manufacturing facility

Contract Manufacturing

Contract Manufacturing for Pharmaceutical Formulations.

Meyonex supports pharmaceutical businesses with dependable contract manufacturing across tablets, capsules, dry powder sachets, and extended formulations including liquid orals, dry syrups, and ointments — backed by modern production infrastructure, ISO 9001:2015–certified operations, monthly installed capacity, and export-oriented logistics near Jawaharlal Nehru Port Trust (Nhava-Sheva).

30 Cr

Tablets / month

10 Cr

Capsules / month

ISO 9001:2015

Manufacturing certified

Tarapur

MIDC, Maharashtra

Overview

A manufacturing partner for growing pharmaceutical businesses.

Meyonex Pharmaceuticals operates as a manufacturing-focused pharmaceutical company supporting the production, packing, and distribution of pharmaceutical formulations. Established in 2015 with early focus on liquid orals, tablets, and capsules, the scope expanded to dry syrups, ointments, and related formats alongside export growth. With an independent manufacturing unit at Tarapur MIDC and installed capacity of 30 Crores tablets, 10 Crores capsules, and 15 Lakhs dry powder sachets per month, the company is positioned to support brands that require scale, quality discipline, and dependable execution.

Our contract manufacturing model is built for businesses looking for a production partner with modern equipment, documented processes, and a facility structured around cGMP-oriented operations. From manufacturing support to formulation-oriented development input, Meyonex is designed for long-term business relationships with a focus on consistency and operational control.

Services

Our contract manufacturing services.

Contract Manufacturing

Full-cycle formulations production

We support the manufacturing of pharmaceutical formulations through a production setup equipped with compression, coating, blending, granulation, capsule filling, and sachet filling capabilities, alongside liquid, dry syrup, and ointment scope — designed to serve businesses that require dependable manufacturing backed by process control and operational efficiency.

Third-Party Manufacturing

Outsource with confidence

Meyonex serves businesses looking to outsource production while maintaining confidence in output quality, process discipline, and facility standards. Our production environment is structured for controlled movement, area segregation, and documented manufacturing practices.

Development Support

R&D and analytical input

Our formulation and development setup includes customized product development programmes, CRO-style collaboration where agreed, and analytical support for product development — from concept and pilot batches through stability-oriented studies, scale-up, plant validation, and technology transfer — managed by a team of five qualified scientists, with regulatory documentation support and IP-aware engagement where required.

Scale-Oriented Production

Built beyond small batches

With installed capacity of 30 Crores tablets and 10 Crores capsules per month, plus 15 Lakhs dry powder sachets per month, Meyonex is built to support businesses that need more than a small-batch setup. Extended formulations capability further expands manufacturing flexibility for partner programs.

Dosage Capabilities

Solid dosage forms — core equipment-backed manufacturing.

This section highlights tablets, capsules, and oral powder as the primary equipment-backed formats; Meyonex’s broader scope also includes liquid orals, dry syrups, and ointments across the formulations portfolio.

Dosage Form

Tablets

High-volume oral solid manufacturing for tablet dosage forms.

Tablet manufacturing is supported through multiple compression machines with automatic weigh control (AMC), coating systems, rapid mixer granulators, fluid bed dryers, octagonal blenders, and tablet inspection with auto-rejection on equipped lines — allowing Meyonex to support high-volume production with weight discipline and controlled operations.

Production Equipment

01Compression machines with automatic weigh control (AMC)
02Tablet inspection with auto-rejection (where configured)
03Auto coater
04Conventional coating pan
05Rapid mixer granulators (RMG)
06Fluid bed dryers (FBD)
07Octagonal blenders

Production Capacity

Built for commercial-scale output.

Meyonex combines installed production strength with a facility layout, equipment base, and quality-focused systems designed to support controlled manufacturing at scale. For partners evaluating fit, capacity is not only about output volume — it is also about readiness.

Tablets / Month

30 Cr

Installed monthly capacity

Capsules / Month

10 Cr

Installed monthly capacity

Dry powder sachets / Month

15 Lakhs

Installed monthly capacity

Tablets / Year

360 Cr

Annualized (×12)

Capsules / Year

120 Cr

Annualized (×12)

Dry powder sachets / Year

180 Lakhs

Annualized (×12)

Facility Infrastructure

Infrastructure that supports reliable manufacturing.

Meyonex operates from an independent manufacturing unit built in line with cGMP-oriented facility principles. The plant spans production, packing, warehouse, quality, microbiology, formulation and development, utility, and assurance areas distributed across functional floors to support organised manufacturing flow.

The premises include epoxy-coated flooring, GMP doors with view panels, fire safety systems, smoke detectors, and dedicated effluent treatment support. The production department is equipped with compression machines featuring automatic weigh control (AMC), auto coater, conventional coating pan, RMGs, FBDs, octagonal blenders, tablet inspection with auto-rejection on configured lines, capsule filling machines, and dry powder sachet filling machinery.

3,099 sq.m

Plant area

31 Units

HVAC infrastructure

3 Levels

Functional layout

cGMP

Premises norms

Meyonex manufacturing infrastructure

Quality Systems

Quality-focused systems at every stage.

Contract manufacturing depends on more than machines — it depends on systems, traceability, and environmental control. Meyonex's facility is designed with unidirectional movement of men and materials, pressure and physical barriers including door interlocking, and separate activity areas to reduce cross-contamination risk. Data generated through laboratory systems is maintained in real-time software environments with audit trail support.

The quality control setup includes instruments such as HPLC systems, FTIR, UV spectrophotometer, dissolution testing, stability chambers, incubators, and autoclaves — supporting analytical control, product evaluation, and stability-oriented quality monitoring as part of the manufacturing support environment.

Unidirectional material and personnel flow
Physical and pressure barriers for contamination control
Audit-trail-supported data systems
In-house QC: HPLC, FTIR, UV, dissolution, stability support
Microbiology lab for sterility and microbiological testing

QC Instrumentation

HPLC Systems
FTIR Spectrophotometer
UV Spectrophotometer
Dissolution Testing
Stability Chambers
Incubators
Autoclaves
Microbiological Testing Equipment

Why Meyonex

Why businesses choose Meyonex.

01

Commercial-Scale Capacity

Installed output of 30 Crores tablets and 10 Crores capsules per month enables Meyonex to support scale requirements well beyond small manufacturing volumes.

02

Formulations manufacturing focus

The facility is structured around tablets, capsules, and oral powder as core equipment-backed formats, within a broader formulations scope that includes liquids, dry syrups, and ointments.

03

Equipment-Ready Plant

A strong production equipment base supports granulation, blending, compression with AMC, coating, capsule filling, inspection with auto-rejection where configured, and powder filling workflows without reliance on external capacity.

04

Quality Control Infrastructure

In-house QC instruments and control systems — including HPLC, FTIR, UV, dissolution, and stability support — strengthen partner confidence through integrated analytical oversight.

05

Export-Oriented Profile

Meyonex operates as both a manufacturer and exporter of finished formulations, with a business profile oriented toward domestic and international market supply.

06

Structured Development Support

A team of 5 qualified scientists supports product development and formulation input, enabling Meyonex to add technical value beyond pure production execution.

Engagement

How we work with partners.

Every manufacturing relationship begins with clarity around product requirements, dosage form, production scale, and business expectations. Below is a simplified view of the typical engagement pathway.

01

Requirement Discussion

Share your product category, dosage form, and manufacturing scope.

02

Technical Review

Align on production suitability, capability, and manufacturing pathway.

03

Planning & Documentation

Finalise batch planning, production approach, and execution framework.

04

Manufacturing & QC

Execute production through controlled manufacturing and QC systems.

05

Release & Delivery

Support batch release and movement toward dispatch and market supply.

Get in Touch

Looking for a reliable manufacturing partner?

Whether you are expanding an existing pharma brand or evaluating a new manufacturing relationship, Meyonex offers the infrastructure, production capability, and quality-focused environment needed for dependable pharmaceutical formulations manufacturing.

FAQ

Common questions.